Birch Grove Capital’s Tenet Healthcare THC Stock Holding History

Birch Grove Capital’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-57,700	Closed	-$3M	–	53
2021 Q1	$3M	Buy	+57,700	New	+$2.92M	1.3%	25

Other funds holding THC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Centerbridge Partners New York $38.1M AUM 9.24% 1-Year Est. Return

Birch Grove Capital's THC Position: Q2 2021 in Review

Birch Grove Capital sold out of Tenet Healthcare (THC) in Q2 2021, closing a stake of 57,700 shares — an estimated $3M sold.

Birch Grove Capital first reported a position in THC in Q1 2021 and held it in 1 quarter. The position peaked at $3M in Q1 2021. 322 funds tracked by Wall St. Rank hold THC as of Q2 2021.

Birch Grove Capital reported no remaining Tenet Healthcare position as of Q2 2021 after selling out during the quarter.
Birch Grove Capital sold 57,700 Tenet Healthcare shares in Q2 2021, an estimated $3M.
Birch Grove Capital first reported a position in Tenet Healthcare in Q1 2021 and held it in 1 quarter.
Birch Grove Capital's Tenet Healthcare position peaked at $3M in Q1 2021.
322 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2021.

Based on Birch Grove Capital's 13F filing for Q2 2021, filed 16 Aug 2021.